CIK 0001314102
- Non-accelerated filer
- Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262774444
- Phone
- +1 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-04 | Cormorant Asset Management, LP 10% owner | Purchase | +53,109 | $26.73 | $1.4M | 5,223,561 |
| 2023-12-04 | Cormorant Asset Management, LP 10% owner | Purchase | +27,425 | $27.87 | $764K | 5,250,986 |
| 2023-12-04 | Cormorant Asset Management, LP 10% owner | Purchase | +8,168 | $28.78 | $235K | 5,259,154 |
| 2023-12-04 | Cormorant Asset Management, LP 10% owner | Purchase | +18,601 | $29.91 | $556K | 5,277,755 |
| 2023-12-04 | Cormorant Asset Management, LP 10% owner | Purchase | +15,582 | $30.74 | $479K | 5,293,337 |
| 2023-12-04 | Cormorant Asset Management, LP 10% owner | Purchase | +86,713 | $31.83 | $2.8M | 5,380,050 |
| 2023-12-04 | Cormorant Asset Management, LP 10% owner | Purchase | +41,824 | $33.08 | $1.4M | 5,421,874 |
| 2023-12-04 | Cormorant Asset Management, LP 10% owner | Purchase | +19,866 | $33.75 | $670K | 5,441,740 |
| 2023-12-04 | Cormorant Asset Management, LP 10% owner | Purchase | +8,260 | $34.49 | $285K | 5,450,000 |
| 2023-10-16 | Duty Stuart Director | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2023-10-16 | Elston George Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2023-09-01 | EW Healthcare Partners, L.P. 10% owner | Sale | −20,000 | $9.90 | $198K | 3,490,921 |
| 2023-09-01 | EW Healthcare Partners, L.P. 10% owner | Sale | −20,000 | $9.90 | $198K | 3,490,921 |
| 2023-08-31 | EW Healthcare Partners, L.P. 10% owner | Sale | −71,478 | $10.17 | $727K | 3,517,938 |
| 2023-08-31 | EW Healthcare Partners, L.P. 10% owner | Sale | −7,017 | $11.02 | $77K | 3,510,921 |
| 2023-08-30 | EW Healthcare Partners, L.P. 10% owner | Sale | −60,649 | $10.92 | $662K | 3,589,743 |
| 2023-08-30 | EW Healthcare Partners, L.P. 10% owner | Sale | −327 | $11.36 | $4K | 3,589,416 |
| 2023-08-29 | EW Healthcare Partners, L.P. 10% owner | Sale | −87,289 | $10.74 | $938K | 3,650,957 |
| 2023-08-29 | EW Healthcare Partners, L.P. 10% owner | Sale | −565 | $11.56 | $7K | 3,650,392 |
| 2023-08-28 | EW Healthcare Partners, L.P. 10% owner | Sale | −60,858 | $11.71 | $713K | 3,738,246 |
Page 21 of 31 · 616 trades